Latest Health News

Page 51 of 212
Artrya Limited has landed a significant three-year commercial agreement with Northeast Georgia Health System, marking its second U.S. customer for the AI-powered Salix platform. This deal accelerates Artrya’s footprint in cardiovascular diagnostics across a major U.S. health network.
Ada Torres
Ada Torres
8 Dec 2025
Talius Group appoints seasoned executive Pat Howard as CEO, with founder Graham Russell shifting to a strategic growth role, signalling a new phase of expansion and innovation.
Victor Sage
Victor Sage
8 Dec 2025
RLF AgTech's second-year durian trial in Vietnam confirms a 38% yield increase and significant plant growth improvements, suggesting a potential 10-fold return on investment with minimal cost rise.
Ada Torres
Ada Torres
8 Dec 2025
Matrix Composites & Engineering has fully redeemed its $7.5 million convertible note, replacing it with a new term loan facility from NAB that offers improved terms and a streamlined debt structure.
Victor Sage
Victor Sage
8 Dec 2025
Island Pharmaceuticals has been granted a pivotal US patent extending protection for its antiviral drug Galidesivir as a Covid-19 treatment until 2042, reinforcing its strategic position in the antiviral market.
Ada Torres
Ada Torres
5 Dec 2025
Terragen Holdings has received nearly $1 million in R&D tax incentives, reinforcing its cash position and fueling ongoing development of its innovative agricultural biotech products.
Ada Torres
Ada Torres
4 Dec 2025
ECS Botanics is set to launch AVANI AVA, a new medicinal cannabis range specifically designed for women’s health, aiming to capture a growing market segment with targeted formulations.
Ada Torres
Ada Torres
4 Dec 2025
Neurizon Therapeutics has completed manufacturing three GMP registration batches of its lead ALS drug candidate NUZ-001 ahead of schedule, paving the way for FDA submissions and clinical trial enrollment.
Ada Torres
Ada Torres
4 Dec 2025
Island Pharmaceuticals has submitted critical responses to the FDA, advancing the development of its antiviral Galidesivir under the Animal Rule pathway. The company awaits FDA feedback expected by early January 2026, setting the stage for upcoming Marburg virus studies.
Victor Sage
Victor Sage
4 Dec 2025
OMG Group has reported a record-breaking November with $720,000 in sales, driving a 68% revenue increase year-to-date. Strong ecommerce and retail growth set the stage for a promising summer season.
Victor Sage
Victor Sage
4 Dec 2025
Nuix Limited has announced its acquisition of Paris-based graph intelligence firm Linkurious for up to €20 million, aiming to enhance its AI-driven data analytics capabilities and expand its global footprint.
Sophie Babbage
Sophie Babbage
4 Dec 2025
Queste Communications reported a slight net cash outflow from operations in November 2025 but maintains robust liquidity supported by a substantial loan facility and liquid ASX-listed investments.
Claire Turing
Claire Turing
3 Dec 2025